RTX Corp HR chief Dantaya Williams sells 9,071 shares

Q: How many RTX shares did Dantaya M. Williams sell, and at what price?

Dantaya M. Williams sold 9,071 RTX common shares at $201.6951 per share on October 30, 2026. No Rule 10b5-1 plan is reported for the transactions.

Q: How were Dantaya M. Williams's RTX Stock Appreciation Rights settled?

The 17,000 Stock Appreciation Rights were settled in shares: Williams acquired 17,000 common shares at a $94.04 exercise price, with 7,929 shares returned to RTX and 9,071 sold at $201.6951 per share.

The settlement involved shares returned to RTX and sold as common stock, while 5,079 common shares were held through the Savings Plan Trustee.

Available on EDGAR 11/03/2026 - 05:03 PM EST Accepted by SEC EDGAR 11/03/2026 - 05:02 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

At RTX Corp, EVP & Chief HR Officer Dantaya M. Williams exercised 17,000 Stock Appreciation Rights on October 30, 2026, acquiring 17,000 common shares at the $94.04 award exercise price. In the settlement, 7,929 shares were returned to RTX and 9,071 shares were sold at $201.6951 per share. The reported SAR position afterward was 31,400, and 5,079 common shares were held indirectly by the Savings Plan Trustee. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Williams Dantaya M

Role EVP & Chief HR Officer

Sold 9,071 shs ($1.83M)

Approx. gross sale proceeds $1.83M

Approx. exercise cost $1.60M

Share of Position Sold 34.9%

Type	Security	Shares	Price	Value
Exercise	Stock Appreciation Right	17,000	$0.00	$0.00
Exercise	Common Stock ^F1	17,000	$94.04	$1.60M
Disposition	Common Stock	7,929	$201.62	$1.60M
Sale	Common Stock	9,071	$201.6951	$1.83M
Holding	Common Stock	--	--	--

Holdings After Transaction: Stock Appreciation Right — 31,400 contracts (Direct); Common Stock — 16,930.4601 shares (Direct); Common Stock — 5,079 shares (Indirect, By Savings Plan Trustee)

Holdings Before and After: Stock Appreciation Right, 48,400 to 31,400 contracts (Direct); Common Stock, 16,930.4601 to 16,930.4601 shares (Direct)

Footnotes (1)

F1. The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

Key Figures

Stock Appreciation Rights exercised: 17,000 rights Award exercise price: $94.04 per share Shares returned to issuer: 7,929 shares +4 more

7 metrics

Stock Appreciation Rights exercised 17,000 rights October 30, 2026

Award exercise price $94.04 per share October 30, 2026

Shares returned to issuer 7,929 shares October 30, 2026

Common shares sold 9,071 shares October 30, 2026

Sale price $201.6951 per share October 30, 2026

SAR position after transaction 31,400 SARs Reported following the October 30, 2026 transaction

Common shares held by Savings Plan Trustee 5,079 shares Indirect holding reported October 30, 2026

Key Terms

Stock Appreciation Rights (SARs), exercise price per share, exempt acquisition, simultaneous sale back to the issuer

4 terms

Stock Appreciation Rights (SARs) financial

"The Stock Appreciation Rights (SARs) were settled in shares"

exempt acquisition regulatory

"treated as an exempt acquisition of the shares underlying the SARs"

simultaneous sale back to the issuer financial

"and a simultaneous sale back to the issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RTX shares did Dantaya M. Williams sell, and at what price?

Dantaya M. Williams sold 9,071 RTX common shares at $201.6951 per share on October 30, 2026. No Rule 10b5-1 plan is reported for the transactions.

How were Dantaya M. Williams's RTX Stock Appreciation Rights settled?

The 17,000 Stock Appreciation Rights were settled in shares: Williams acquired 17,000 common shares at a $94.04 exercise price, with 7,929 shares returned to RTX and 9,071 sold at $201.6951 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Dantaya M

(Last)

(First)

(Middle)

1000 WILSON BLVD.

(Street)

ARLINGTON

VIRGINIA

22209

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RTX Corp [ RTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & Chief HR Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/30/2026		M		17,000⁽¹⁾	A	$94.04	33,930.4601	D
Common Stock	10/30/2026		D		7,929	D	$201.62	26,001.4601	D
Common Stock	10/30/2026		S		9,071	D	$201.6951	16,930.4601	D
Common Stock								5,079	I	By Savings Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Appreciation Right	$94.04	10/30/2026		M			17,000	02/15/2025	02/14/2032	Common Stock	17,000	$0.0000	31,400	D

Explanation of Responses:

1. The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

	/s/ Edward G. Perrault as Attorney-in-Fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR